Compare AURE & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AURE | DRIO |
|---|---|---|
| Founded | 2018 | 2011 |
| Country | | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.5M | 84.1M |
| IPO Year | N/A | 2013 |
| Metric | AURE | DRIO |
|---|---|---|
| Price | $2.02 | $11.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $50.00 |
| AVG Volume (30 Days) | ★ 473.5K | 17.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 9.05 |
| Revenue | N/A | ★ $7,394,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $16.15 |
| P/E Ratio | ★ N/A | $1.23 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $0.18 | $0.38 |
| 52 Week High | $0.67 | $17.74 |
| Indicator | AURE | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 94.42 | 50.53 |
| Support Level | $0.18 | $10.00 |
| Resistance Level | $0.26 | $12.23 |
| Average True Range (ATR) | 0.05 | 0.79 |
| MACD | 0.12 | 0.13 |
| Stochastic Oscillator | 91.24 | 60.61 |
Aurelion Inc is engaged in providing private wealth management and asset management services to high-net-worth and ultra-high-net-worth individuals by identifying and purchasing well-matched wealth management products offered by third-party providers. Its subsidiary operates a wealth management business that works with licensed product brokers in Hong Kong, currently consisting solely of insurance brokers distributing insurance products, and assists in customizing wealth management investment portfolios for clients. The Company generates revenue for its subsidiaries' wealth management business from product brokers in the form of referral fees, which are calculated based on the value of wealth management products purchased by clients from such brokers.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.